Product NDC: | 45802-076 |
Proprietary Name: | Imiquimod |
Non Proprietary Name: | imiquimod |
Active Ingredient(s): | 50 mg/1000mg & nbsp; imiquimod |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 45802-076 |
Labeler Name: | Perrigo New York Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020723 |
Marketing Category: | NDA |
Start Marketing Date: | 20100420 |
Package NDC: | 45802-076-62 |
Package Description: | 24 PACKET in 1 CARTON (45802-076-62) > 250 mg in 1 PACKET (45802-076-00) |
NDC Code | 45802-076-62 |
Proprietary Name | Imiquimod |
Package Description | 24 PACKET in 1 CARTON (45802-076-62) > 250 mg in 1 PACKET (45802-076-00) |
Product NDC | 45802-076 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | imiquimod |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20100420 |
Marketing Category Name | NDA |
Labeler Name | Perrigo New York Inc. |
Substance Name | IMIQUIMOD |
Strength Number | 50 |
Strength Unit | mg/1000mg |
Pharmaceutical Classes | Increased Cytokine Activity [PE],Increased Cytokine Production [PE],Interferon Inducers [MoA] |